Pneumococcal meningitis and endocarditis in an infant: possible improved survival with factor V Leiden mutation

Sitikant Mohapatra1, Assaf Doulah2, Elspeth Brown3

  • 1Paediatric Intensive Care Unit, Leeds Teaching Hospitals NHS Trust, Leeds, LS1 3EX, UK. sitikant1@yahoo.co.uk.

Insights

Factor V Leiden mutation may improve outcomes in critically ill children with severe pneumococcal infections. This rare case highlights the potential protective effect of Factor V Leiden in pediatric sepsis.

Area of Science:

  • Pediatric Infectious Diseases
  • Hematology
  • Critical Care Medicine

Background:

  • Invasive pneumococcal disease (IPD) is a significant cause of morbidity and mortality in children.
  • Streptococcus pneumoniae endocarditis is a rare but severe complication of IPD, particularly in healthy infants.
  • The role of genetic factors in the outcomes of severe pediatric infections is an area of ongoing research.

Observation:

  • A previously healthy 10-month-old infant presented with sepsis and meningitis.
  • The infant was diagnosed with Streptococcus pneumoniae meningitis and endocarditis.
  • Genetic testing revealed the presence of a Factor V Leiden (FVL) mutation.

Findings:

  • Despite initial severe complications, the infant with Streptococcus pneumoniae meningitis and endocarditis, who also had the FVL mutation, made a complete recovery.
  • Emerging evidence suggests a correlation between FVL mutation and improved outcomes in critically ill children.
  • The presence of FVL mutation may confer a protective effect in severe pediatric invasive pneumococcal disease.

Implications:

  • The findings suggest that Factor V Leiden mutation might be associated with better prognoses in critically ill children with severe bacterial infections.
  • Further research is warranted to elucidate the mechanisms underlying this potential protective association.
  • This case underscores the importance of considering genetic predispositions in managing severe pediatric sepsis and invasive pneumococcal disease.

Related Concept Videos

Endocarditis III: Medical Management01:18

Endocarditis III: Medical Management

Infective endocarditis management involves a multifaceted approach encompassing infection prevention, lifestyle modifications, pharmacological therapy, and surgical management.Infection Prevention:Hand Hygiene: Thorough handwashing is crucial to prevent the spread of infection. Hand hygiene should be performed regularly, especially before and after using the restroom.Oral Hygiene: Good oral hygiene is essential. It includes brushing teeth immediately after waking up and before bed, flossing...
282
Endocarditis I: Introduction01:25

Endocarditis I: Introduction

Introduction:Endocarditis is the infection of the endocardium, the inner lining of the heart and its valves. When the heart muscle is involved, the condition is termed myocarditis, while an infection of the outer lining is called pericarditis. Infective endocarditis (IE) primarily affects the endocardium, where pathogens adhere to the valves or lining, forming vegetation that can lead to severe complications. Infective endocarditis occurs when microorganisms, usually bacteria from other body...
590
Endocarditis II: Clinical Features of Infective Endocarditis01:25

Endocarditis II: Clinical Features of Infective Endocarditis

Endocarditis can present various clinical features depending on the causative organism and the patient's underlying health conditions. Initially, the clinical features of infective endocarditis develop gradually, presenting with nonspecific symptoms that can be easily mistaken for other illnesses.General SymptomsEarly symptoms of infective endocarditis are fever, chills, weakness, malaise, fatigue, and weight loss. These symptoms reflect the systemic nature of the infection and the body's...
605
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
963
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
3.4K
Mitral Valve Prolapse III: Nursing Management01:19

Mitral Valve Prolapse III: Nursing Management

The nursing management of Mitral Valve Prolapse, or MVP, centers around patient education, symptom monitoring, and lifestyle modifications.Patient Education on MVP Diagnosis and Heredity: Nurses should provide comprehensive education about MVP, a condition where the mitral valve does not close appropriately during heartbeats. This education often includes the condition's pathophysiology, symptoms, and potential complications, like arrhythmias or mitral regurgitation. Though not fully...
458